-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Upgrades Inspire Medical Systems to Outperform, Announces $85 Price Target

Benzinga·08/04/2026 17:10:06
語音播報
Oppenheimer analyst Suraj Kalia upgrades Inspire Medical Systems (NYSE:INSP) from Perform to Outperform and announces $85 price target.